New York Headache blog

by Dr. Alexander Mauskop
subscribe to our newsletter
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
We won’t share your data with third parties. Ever.
January 20, 2022
Intranasal ketamine for cluster headaches
January 20, 2022
Cluster headaches are considered to cause the worst pain imaginable. We have a variety of medications – both acute and preventive – that help relieve the pain of cluster headaches. For some, none of these treatments...
Read article
January 13, 2022
Marijuana increases the risk of car accidents
January 13, 2022
I’ve been prescribing medical marijuana (MM) since 2016 when it became legal in New York. We still lack controlled clinical trials of MM for the treatment of migraines. Most of my patients who find MM useful report that it...
Read article
January 6, 2022
Pandemic worsens headaches in children
January 6, 2022
Worsening of headaches in children is one of many deleterious effects of the pandemic and measures to control it. A survey of children in a headache clinic at the Children’s National Hospital in Washington DC by Dr. DiSabell...
Read article
December 28, 2021
If you are having surgery and have had migraines, read this!
December 28, 2021
There is a new and surprising connection between postoperative nausea and vomiting (PONV) and migraines. It offers a very effective treatment that will relieve the suffering of tens of thousands of patients. Many migraine patients tell...
Read article
December 18, 2021
Repetitive transcranial magnetic stimulation relieves migraines
December 18, 2021
Magnetic stimulation with a single pulse has been shown to be effective in aborting a migraine attack with the eNeura Spring TMS device. Repetitive magnetic stimulation rTMS) of the brain has been shown to relieve depression...
Read article
November 28, 2021
Sublingual ketamine for pain
November 28, 2021
Ketamine was approved by the FDA in 1970 and was originally used for the induction of anesthesia. It has been shown to relieve depression and is also widely used to treat pain. For depression, it is approved by the FDA in a nasal...
Read article
November 8, 2021
Zürich headache conference
November 8, 2021
With Swiss colleagues Drs. Caterina Podella, Livia Granata, and Reto Agosti at the headache conference held on November 4, 2021, in Zürich. Dr. Podella presented a very comprehensive approach to the treatment of migraine...
Read article
October 31, 2021
Men with migraine and cluster headaches can also have hormonal issues
October 31, 2021
The influence of estrogen on migraines in women is well established – women often experience migraines before or during menstruation and ovulation and their migraines usually subside during pregnancy and menopause...
Read article
October 21, 2021
If you see a friend respond to treatment, you are more likely to respond as well
October 21, 2021
The placebo effect is a bane of clinical trials. It is, however, a great tool in clinical practice. It is unethical to prescribe an actual placebo but there is no reason not to try to enhance the placebo effect when prescribing any...
Read article
October 14, 2021
Dr. Mauskop to speak on refractory migraines in Zurich, Switzerland
October 14, 2021
I am honored to participate in a symposium on headache management,“THE CHALLENGE OF MIGRAINE AND CLUSTER HEADACHES”. The title of my presentation is The challenge of migraine: new perspectives in refractory cases...
Read article
October 11, 2021
Response to drugs is influenced by psychological factors
October 11, 2021
To gain FDA approval a drug has to be shown to be better than a placebo. The placebo effect is a well-established psychological contributor to the efficacy of most treatments. A group of Italian researchers just published...
Read article
October 2, 2021
FDA approves Qulipta (atogepant), a new preventive migraine drug
October 2, 2021
Atogepant (Qulipta) is a new migraine drug that was just approved by the FDA for the preventive treatment of migraines. It is the third drug in the family of gepants. Gepants block the CGRP receptor. CGRP is a chemical...
Read article
September 27, 2021
A large study shows that the weather affects pain
September 27, 2021
Many migraine sufferers report that their migraines are brought on by the weather. High humidity, high temperatures, and changes in barometric pressure are the most commonly reported triggers. I’ve seen some patients for whom...
Read article
September 18, 2021
Migraines are less common in people with diabetes
September 18, 2021
Two large studies have established that if you have diabetes you are less likely to suffer from migraines. The first study was done on the entire population of Norway. The authors concluded that both type 1 and type 2 diabetes...
Read article
September 11, 2021
Julie Mauskop on David Zwirner’s Platform
September 11, 2021
Patients coming to the New York Headache Center have enjoyed seeing my daughter Julie’s artwork since she was 11. This was not just a childhood interest – Julie graduated from the Rhode Island School of Design with a degree...
Read article
September 6, 2021
A new, better DHE nasal spray is approved for acute migraines
September 6, 2021
Trudhesa is a new formulation of dihydroergotamine (DHE) nasal spray just approved by the FDA. It appears to be more effective than the original DHE nasal spray (Migranal) that was introduced in 1997. Ergotamine, the first migraine...
Read article
August 30, 2021
Placebo really works, even if you know it’s placebo
August 30, 2021
The placebo effect is a bane of clinical trials. A drug is considered ineffective if it is only as good as a placebo. And placebo can be quite good. Intriguingly, the placebo effect in clinical trials has been getting stronger over the past...
Read article
August 22, 2021
Another review of The End of Migraines: 150 Ways to Stop Your Pain
August 22, 2021
It is gratifying to know that my colleagues consider my new book, The End of Migraines: 150 Ways to Stop Your Pain, to be useful for patients with migraines as well as doctors who treat them. Dr. Uwe Reuter of Charité Universitätsmedizin...
Read article
August 8, 2021
More of the omega-3 and less of omega-6 fatty acids helps migraines
August 8, 2021
Migraine can be triggered by many foods, including sugar, chocolate, smoked, pickled, cured, dried, and fermented foods. There are also foods that can help with migraines. These are magnesium-rich dark leafy vegetables...
Read article
August 2, 2021
Magnesium can reduce the risk of aneurysm formation and rupture
August 2, 2021
Many patients with headaches are concerned about having a brain aneurysm. It is rare for an aneurysm to cause ongoing headaches. An aneurysm usually causes one very severe headache when it ruptures and causes...
Read article
July 26, 2021
Naratriptan is the most effective triptan?
July 26, 2021
In the US, we are lucky to have seven different triptans available in the pharmacies. Five of them – sumatriptan, rizatriptan, zolmitriptan, eletriptan, and almotriptan are considered to be more effective than the other two – naratriptan...
Read article
July 17, 2021
Chronic pain causes cognitive decline
July 17, 2021
Many patients with chronic migraines complain of memory, word-finding, and other cognitive difficulties. I tell them that once we find an effective treatment for their migraines, their cognitive abilities should improve...
Read article
July 10, 2021
Occipital nerve stimulation relieves chronic cluster headaches
July 10, 2021
The pain of cluster headaches is considered to be the worst of all headaches. Hence the moniker, suicide headaches. Thankfully, it is a rare condition. Episodic cluster headaches affect a little over 0.1% of the population or approximately...
Read article
June 28, 2021
Mindfulness-based stress reduction helps migraines
June 28, 2021
It’s been a few years since I wrote about meditation. There is little doubt that it helps migraine sufferers. Unlike drugs, meditation is harder to test in clinical trials. However, we do have many imaging studies showing the effect...
Read article
June 17, 2021
Dividing migraines into chronic and episodic was a costly mistake
June 17, 2021
The international classification of headache disorders lists many different types of migraines – migraine with aura, hemiplegic, retinal, chronic, and others. Chronic migraine is present if a person has a headache on 15 or more...
Read article
June 7, 2021
Erenumab relieves trigeminal neuralgia – another case series
June 7, 2021
Trigeminal neuralgia (TN) is an extremely painful and often debilitating condition. Many people respond to the standard therapy with epilepsy drugs such as carbamazepine (Tegretol) or oxcarbazepine (Trileptal). Botox injections...
Read article
June 2, 2021
Dr. Allan Purdy’s review of my new book
June 2, 2021
A publication of the American Headache Society, Headache, The Journal of Head and Face Pain, has just published Dr. Allan Purdy’s most generous review of my new book, The End of Migraines: 150 Ways to Stop Your Pain...
Read article
May 27, 2021
Nurtec is the first drug approved for acute and preventive treatment of migraines
May 27, 2021
Biohaven, the manufacturer of rimegepant (Nurtec ODT) just received FDA approval to market this drug for the prevention of migraines. Rimegepant was approved in January of 2020 for the acute treatment of migraine headaches...
Read article
May 23, 2021
Predicting success of surgery for trigeminal neuralgia
May 23, 2021
Trigeminal neuralgia (TN) is an extremely painful condition. Patients describe the pain as electric shocks going through the face. The most common or classic form of TN is caused by the compression of the trigeminal nerve as...
Read article
May 17, 2021
The pendulum swings and hits hard patients on opioid drugs
May 17, 2021
The opioid epidemic has claimed many lives. Overprescribing by doctors has certainly played a role. The push to use opioids more liberally started in the late 1980s. This promotion by many pain experts even led to pain...
Read article